Toxic multinodular goiter

Thyroid function tests and clinical examination should be monitored after treatment. There are no specific guidelines for the monitoring schedule. One approach is to monitor at 6 weeks, 3 months, 6 months, and 12 months, and then yearly after I-131 therapy.

There is no evidence for efficacy of follow-up CBCs in predicting agranulocytosis. Baseline values are recommended. Immediate patient reporting of any symptoms of infection is mandatory.